Difficulty: Medium
Average Score: 69%
Practice
A client is starting therapy with bicalutamide. Which of the following adverse effects should the nurse instruct the client to monitor?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Gynecomastia. Bicalutamide is an androgen receptor antagonist commonly used in the treatment of prostate cancer. Gynecomastia, the development of breast tissue in males, is a well-known adverse effect of bicalutamide due to its anti-androgenic properties. It is crucial for the nurse to educate the client on monitoring for signs of gynecomastia to ensure early detection and intervention.
Muscle pain (option A) is not typically associated with bicalutamide use and is therefore not a priority adverse effect to monitor. Flushing (option B) is also not a common side effect of bicalutamide and is unlikely to occur. Hyperglycemia (option D) is not directly related to bicalutamide use and is more commonly associated with other medications or conditions.
In an educational context, understanding the adverse effects of medications is essential for nurses to provide safe and effective care to their clients. By knowing the expected side effects of specific drugs, nurses can educate clients on what to monitor for and when to seek medical attention. This knowledge enhances patient safety and promotes better outcomes in pharmacological therapy.
Muscle pain (option A) is not typically associated with bicalutamide use and is therefore not a priority adverse effect to monitor. Flushing (option B) is also not a common side effect of bicalutamide and is unlikely to occur. Hyperglycemia (option D) is not directly related to bicalutamide use and is more commonly associated with other medications or conditions.
In an educational context, understanding the adverse effects of medications is essential for nurses to provide safe and effective care to their clients. By knowing the expected side effects of specific drugs, nurses can educate clients on what to monitor for and when to seek medical attention. This knowledge enhances patient safety and promotes better outcomes in pharmacological therapy.